Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure
Author(s) -
Terrence M. Yau,
Francis D. Pagani,
Donna Mancini,
Helena Chang,
Anuradha Lala,
Y. Joseph Woo,
Michael A. Acker,
Craig H. Selzman,
Edward G. Soltesz,
John A. Kern,
Simon Maltais,
Éric Charbonneau,
Stephanie Pan,
Mary E. Marks,
Ellen Moquete,
Karen O’Sullivan,
Wendy C. TaddeiPeters,
Lydia K. McGowan,
China Green,
Eric A. Rose,
Neal Jeffries,
Michael K. Parides,
Richard D. Weisel,
Marissa A. Miller,
Judy Hung,
Patrick T. O’Gara,
Alan J. Moskowitz,
Annetine C. Gelijns,
Emilia Bagiella,
Carmelo A. Milano
Publication year - 2019
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2019.2341
Subject(s) - medicine , weaning , mesenchymal stem cell , heart failure , ventricular assist device , cardiology , pathology
Left ventricular assist device (LVAD) therapy improves myocardial function, but few patients recover sufficiently for explant, which has focused attention on stem cells to augment cardiac recovery.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom